Covered recipient · General Payments record
MARTINA DIANA PORTER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$298.42
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $277.48 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $55.79 | 3 |
| PFIZER INC. | $38.03 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $34.45 | 1 |
| DEXCOM, INC. | $23.35 | 1 |
| Novo Nordisk AS | $21.86 | 1 |
| Acerta Pharma LLC | $20.98 | 1 |
| Phathom Pharmaceuticals, Inc. | $18.28 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.22 | 1 |
| ABBVIE INC. | $18.16 | 1 |
| GlaxoSmithKline, LLC. | $14.52 | 1 |
| Merck Sharp & Dohme Corporation | $13.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.16 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108031869 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.98 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104514378 | CMS |
| Boston Scientific Corporation | $34.45 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092344750 | CMS |
| Dexcom, Inc. | $23.35 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153377161 | CMS |
| GlaxoSmithKline, LLC. | $14.52 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116286127 | CMS |
| Lilly USA, LLC | $14.26 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135815612 | CMS |
| Lilly USA, LLC | $17.15 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135813787 | CMS |
| Lilly USA, LLC | $24.38 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135743844 | CMS |
| Merck Sharp & Dohme LLC | $13.84 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141864311 | CMS |
| Novo Nordisk Inc | $21.86 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100453632 | CMS |
| PFIZER INC. | $21.72 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132054790 | CMS |
| PFIZER INC. | $16.31 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131084325 | CMS |
| Phathom Pharmaceuticals, Inc. | $18.28 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151197735 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.22 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137809127 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.